Analyst picks & changes

Amgen Inc.

Biogen Inc.

Chiron Corp.

Genelabs Technologies Inc.

Having recently downgraded all the stocks in his biotech universe, Joseph Edelman of Prudential Securities went back and upgraded four from "hold" to "buy," based in part on low prices and in part

Read the full 386 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE